Roivant Sciences (ROIV) Current Leases (2021 - 2026)
Roivant Sciences (ROIV) posted Current Leases of $11.1 million for Q1 2026, up 6.81% on a QoQ basis from $10.4 million in Q4 2025, and up 13.26% year-over-year from $9.8 million in Q1 2025.
Roivant Sciences (ROIV) Current Leases (2021 - 2026) Analysis & Trends
Roivant Sciences' Current Leases history runs 6 years deep, the most recent figure standing at $11.1 million for Q1 2026.
- Quarterly Current Leases rose 13.26% year-over-year to $11.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.1 million (up 13.26% YoY) and the FY2026 annual result came in at $11.1 million, up 13.26% from the prior year.
- Current Leases was $11.1 million for Q1 2026 at Roivant Sciences, up from $10.4 million in the prior quarter.
- Across five years, Current Leases topped out at $11.9 million in Q4 2022 and bottomed at $9.0 million in Q1 2024.
- A 5-year average of $10.5 million and a median of $10.5 million in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases decreased 23.32% — and 2026, when it grew 13.26%.
- Roivant Sciences' Current Leases stood at $11.9 million in 2022, then slipped by 11.68% to $10.5 million in 2023, then retreated by 6.13% to $9.8 million in 2024, then advanced by 6.11% to $10.4 million in 2025, then increased by 6.81% to $11.1 million in 2026.
- Business Quant data shows ROIV's Current Leases at $11.1 million in Q1 2026, $10.4 million in Q4 2025, and $9.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | 11.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.15 Mn |
| Dec 31, 2025 | 10.44 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | 9.40 Mn |
| Mar 31, 2025 | 9.84 Mn |
| Dec 31, 2024 | 9.84 Mn |
| Sep 30, 2024 | 9.52 Mn |
| Jun 30, 2024 | 9.49 Mn |
| Mar 31, 2024 | 8.97 Mn |
| Dec 31, 2023 | 10.48 Mn |
| Sep 30, 2023 | 10.90 Mn |
| Jun 30, 2023 | 11.35 Mn |
| Mar 31, 2023 | 11.69 Mn |
| Dec 31, 2022 | 11.86 Mn |
| Sep 30, 2022 | 11.40 Mn |
| Jun 30, 2022 | 11.86 Mn |
| Mar 31, 2022 | 11.40 Mn |
| Dec 31, 2021 | 11.24 Mn |
| Sep 30, 2021 | 11.52 Mn |
| Jun 30, 2021 | 12.06 Mn |